Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future - GBI Research Reports

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future - GBI Research Reports
Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future
Published Oct 03, 2011
80 pages — Published Oct 03, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research, Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future which provides insights into the global contraceptives market and market forecasts until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts. The report provides an in-depth analysis of the contraceptives most commonly used, such as oral, topical and injectable contraceptives, intrauterine devices, condoms and vaginal rings. The report also examines usage patterns for oral, topical and injectable contraceptives treatment. It also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape, including major companies in the contraceptives market. Finally, the report also includes analysis of mergers and acquisitions (M&A) and licensing agreements that have taken place in the global contraceptives market.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.

GBI Research analysis shows that revenues are projected to increase from $15.5 billion in 2010 to $19.2 in 2017 at a CAGR of 3.1%. Prescription and OTC contraceptives held an 82% and 18% market share, respectively, in 2010. The intrauterine devices market was valued at $1,370.4m in 2010 and revenues are projected to increase to $1,398.1m in 2017, at a CAGR of 0.3%. However, revenues are expected to decline in 2015 due to the patent expiry of Mirena and the availability of low cost hormonal intrauterine devices. Strategic consolidations through acquisition accounted for 31% of M&A deals.

Scope

- The report analyzes the market characterization, pipeline analysis and key M&A trends for oral, topical and injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market.
- Data and analysis on the contraceptives market in leading geographies: the US, the UK, Germany, France, Italy, Spain and Japan.
- Annualized market data for oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 20022010, with forecasts to 2017.
- Market data on the therapeutic landscape, which covers oral, topical and injectable contraceptives, and includes market revenues, treatment usage patterns and annual cost of usage.
- Key drivers and restraints that have had a significant impact on the market.
- The competitive landscape of the contraceptives market, which includes companies such as Bayer, Johnson & Johnson, Reckitt Benckiser, Church & Dwight and Merck.
- Key M&A activities and licensing agreements that took place from 20052011 in the contraceptives market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Align your product portfolio to markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
- Devise a more tailored country strategy through understanding of key drivers and barriers in the contraceptives market.
- Develop key strategic initiatives by understanding the key focus areas of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

  
Source:
Document ID
GBIHC143MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents36
  List of Tables52
  List of Figures72
Contraceptives Market to 2017- Introduction92
  GBI Research Report Guidance101
Contraceptives Market to 2017 - Market Overview116
  Introduction111
  Revenue Forecasts for Contraceptives Market111
    Revenues111
      Global Contraceptives Revenue Share by Geography122
    Annual Cost of Usage for Contraceptives141
    Share of Prescription and OTC Contraceptives151
  Drivers and Barriers for Contraceptives Market161
    Drivers for Contraceptives161
      Increase in Awareness Levels about the Use of Contraceptives161
      Increase in Government Initiatives to Provide Publicly Funded Contraceptives161
      Changes in Beliefs Regarding the Use of Contraceptives161
      Launch of Novel Contraceptives in the Forecast Period161
    Barriers for Contraceptives161
      Side Effects of Contraceptives161
      Patent Expiry of Contraceptives161
Contraceptives Market to 2017- Geographical Landscape176
  The US171
    Revenue171
    Annual Cost of Therapy for Contraceptives181
  Top Five Countries of Europe191
    Revenue191
    Annual Cost of Therapy for Contraceptives201
  Japan211
    Revenue211
    Annual Cost of Therapy for Contraceptives221
Contraceptives Market to 2017 - Therapeutic landscape2318
  Oral Contraceptives231
    Introduction231
    Revenue231
      Geographical Segmentation242
    Annual Cost of Therapy261
    Treatment Usage Patterns272
  Injectables291
    Introduction291
    Revenue291
      Geographical Segmentation302
    Annual Cost of Therapy321
    Treatment Usage Patterns332
  Topical Contraceptives351
    Introduction351
    Revenue351
      Geographical Segmentation362
    Annual Cost of Therapy381
    Treatment Usage Patterns392
Contraceptives Market to 2017 - Devices landscape4114
  Vaginal Ring411
    Introduction411
    Revenue412
    Geographical Segmentation432
    Annual Cost of Usage451
  Intrauterine Devices461
    Introduction461
    Revenue461
    Copper Intrauterine Device and Hormonal Intrauterine Device Share471
    Geographical Segmentation482
    Annual Cost of Usage501
  Condoms511
    Introduction511
    Revenue511
    Geographical Segmentation522
    Annual Cost of Usage541
Contraceptives Market to 2017 - Pipeline Analysis555
  Introduction553
  Profiles of Promising Drugs in the Global Contraceptives Market581
    AG200-15581
      Overview581
      Efficacy581
      Safety581
      Clinical Study Details581
    Yaz Flex581
      Overview581
      Efficacy581
      Safety581
      Clinical Study Details581
    Pill-Plus591
      Overview591
      Efficacy591
      Safety591
      Clinical Study Details591
Contraceptives Market to 2017 - Competitive Landscape608
  Market Share Analysis: Contraceptives Market601
  Drug Profile of Major Marketed Contraceptives601
    Yaz/ Yasmin611
      Overview611
    Mirena611
      Overview611
    Nuvaring611
      Overview611
  Competitive Profiling621
    Bayer621
      Overview621
      SWOT Analysis631
    Johnson &Johnson641
      Overview641
      SWOT Analysis641
    Church &Dwight651
      Overview651
      SWOT Analysis651
    Merck661
      Overview661
      SWOT Analysis661
    Reckitt &Benckiser671
      Overview671
      SWOT Analysis671
Contraceptives Market to 2017 - M&A Landscape689
  M&A Landscape681
    M&A Deals by Year681
    M&A Deals by Value691
    M&A Deals by Geography701
    M&A Deals by Deal Type711
    M&A Deals by Deal Sub-Type721
  R&D Licensing Agreements731
    Deals by Year731
    Deals by Geography741
    Deals by Value751
  Co-Development Agreements761
    Deals by Year761
    Deals by Geography761
Contraceptives Market to 2017 - Appendix774
  Market Definitions771
  Abbreviations771
  Research Methodology774
    Coverage771
    Secondary Research781
    Primary Research781
    Section Methodology781
      Therapeutic Landscape791
      Devices Landscape791
      Geographical Landscape791
      Pipeline Analysis791
      Competitive Landscape801
    Expert Panel Validation801
  Contact Us801
  Disclaimer801
  Sources801

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future" Oct 03, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Contraceptives-Market-to-2017-Hormonal-Contraceptives-and-Strong-Pipeline-to-Drive-the-Growth-in-Future-2115-276>
  
APA:
GBI Research Reports. (2011). Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future Oct 03, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Contraceptives-Market-to-2017-Hormonal-Contraceptives-and-Strong-Pipeline-to-Drive-the-Growth-in-Future-2115-276>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.